Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]
Abstract
[This corrects the article DOI: 10.1016/j.mtbio.2025.102226.].
Fields of Study & Subjects
Tissue Engineering and Regenerative Medicine
Cardiac Fibrosis and Remodeling
Peptidase Inhibition and Analysis
Publication details
- Journal / source
- Materials Today Bio
- Publisher
- Elsevier BV
- Volume
- 37
- Pages
- 103024–103024
- Publication date
- 18 March 2026
- Language
- EN